UBS Group’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-50,000
Closed -$4.45M 8335
2017
Q1
$4.45M Sell
50,000
-572,800
-92% -$47.1M ﹤0.01% 2181
2016
Q4
$44.1M Buy
622,800
+506,900
+437% +$37.8M 0.02% 603
2016
Q3
$9.16M Buy
+115,900
New +$9.89M 0.01% 1495
2016
Q2
Sell
-251,900
Closed -$21.4M 8215
2016
Q1
$21.4M Buy
251,900
+208,600
+482% +$15.5M 0.01% 849
2015
Q4
$3.42M Buy
+43,300
New +$3.41M ﹤0.01% 2295
2015
Q3
Sell
-13,700
Closed -$1.24M 8878
2015
Q2
$1.24M Sell
13,700
-25,100
-65% -$2.42M ﹤0.01% 3393
2015
Q1
$3.9M Sell
38,800
-1,100
-3% -$111K ﹤0.01% 2297
2014
Q4
$4.01M Buy
+39,900
New +$3.98M ﹤0.01% 2292

Other funds holding MJN

UBS Group's MJN Position: Q2 2017 in Review

UBS Group sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 1,947,990 shares — an estimated $174M sold.

UBS Group first reported a position in MJN in Q4 2014 and held it in 10 quarters. The position peaked at $174M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • UBS Group reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • UBS Group sold 1,947,990 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $174M.
  • UBS Group first reported a position in Mead Johnson Nutrition Company in Q4 2014 and held it in 10 quarters.
  • UBS Group's Mead Johnson Nutrition Company position peaked at $174M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.